{"id":225651,"date":"2025-11-22T05:04:48","date_gmt":"2025-11-22T11:04:48","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/11\/arginine-supplementation-curbs-alzheimers-disease-pathology-in-animal-models"},"modified":"2025-11-22T05:04:48","modified_gmt":"2025-11-22T11:04:48","slug":"arginine-supplementation-curbs-alzheimers-disease-pathology-in-animal-models","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/11\/arginine-supplementation-curbs-alzheimers-disease-pathology-in-animal-models","title":{"rendered":"Arginine supplementation curbs Alzheimer\u2019s disease pathology in animal models"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/arginine-supplementation-curbs-alzheimers-disease-pathology-in-animal-models2.jpg\"><\/a><\/p>\n<p>Alzheimer\u2019s disease (AD), a progressive neurodegenerative disorder, is one of the leading causes of dementia worldwide, and currently has no definitive cure. Although antibody-based therapies that target amyloid \u03b2 (A\u03b2) have recently been developed, their clinical effectiveness remains limited. These treatments can be costly and cause immune-related side effects, highlighting the need for safer, affordable, and widely accessible approaches that can slow the progression of AD.<\/p>\n<p>In a study, <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S019701862500155X\" target=\"_blank\">published<\/a> online on October 30, 2025, in <i>Neurochemistry International<\/i>, researchers from Kindai University and collaborating institutions discovered that oral administration of arginine, a naturally occurring amino acid and safe chemical chaperone, effectively suppresses A\u03b2 aggregation and its toxic effects in animal models of AD.<\/p>\n<p>The researchers emphasized that although arginine is available as an over-the-counter dietary supplement, the dosage and administration protocol employed in this study was optimized for research purposes and does not correspond to commercially available formulations.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alzheimer\u2019s disease (AD), a progressive neurodegenerative disorder, is one of the leading causes of dementia worldwide, and currently has no definitive cure. Although antibody-based therapies that target amyloid \u03b2 (A\u03b2) have recently been developed, their clinical effectiveness remains limited. These treatments can be costly and cause immune-related side effects, highlighting the need for safer, affordable, [\u2026]<\/p>\n","protected":false},"author":732,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,19,47],"tags":[],"class_list":["post-225651","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-chemistry","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/225651","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/732"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=225651"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/225651\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=225651"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=225651"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=225651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}